Stocks Market
Vicenne Posts 14% Profit Growth in H1 2026 as Revenue Rises to 591 Million Dirhams
Vicenne reported consolidated revenue of 591 million dirhams for the first half of 2026, marking a 12% year‑on‑year increase, while net profit rose 14% to 94 million dirhams. The company also posted EBITDA of 144 million dirhams, up 14% from the same period last year. Growth was broad‑based across its three divisions—equipment, implantables & reagents, and services—each delivering double‑digit gains. Vicenne reaffirmed its full‑year target of roughly 1.2 billion dirhams in revenue, underscoring confidence in continued demand from public and private healthcare infrastructure investments.
Listen to this article
Unlock audio versions of premium articles and more with a Pro subscription.
Vicenne Reports Strong H1 2026 Performance
Vicenne announced consolidated revenue of 591 million dirhams (MDH) for the first half of 2026, representing a 12% increase compared with the same period in 2025. Net profit rose to 94 MDH, up from 83 MDH a year earlier, which equates to a 14% gain.
Segment‑Level Growth
- Equipment: 347 MDH (+13%)
- Implantables & Reagents: 182 MDH (+10%)
- Services: 63 MDH (+18%)
All three business lines contributed to the top‑line expansion.
EBITDA and Operational Metrics
EBITDA reached 144 MDH, up from 126 MDH in H1 2025—a 14% improvement. The company attributes this to higher volumes and better margin mix across its portfolio.
Outlook and Market Context
Vicenne reconfirms its full‑year revenue target of approximately 1.2 billion dirhams at constant scope. The outlook is underpinned by sustained investment in healthcare infrastructure from both public and private sectors in Morocco and the broader region.